BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32279466)

  • 1. Clinical evaluation of smartphone-based fluorescence imaging for guidance and monitoring of ALA-PDT treatment of early oral cancer.
    Khan S; Hussain MAB; Khan AP; Liu H; Siddiqui S; Mallidi S; Leon P; Daly L; Rudd G; Cuckov F; Hopper C; Bown SG; Akhtar K; Hasan SA; Siddiqui SA; Hasan T; Celli JP
    J Biomed Opt; 2020 Apr; 25(6):1-10. PubMed ID: 32279466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical assessment of a low-cost, hand-held, smartphone-attached intraoral imaging probe for 5-aminolevulinic acid photodynamic therapy monitoring and guidance.
    Khan S; Song B; Mallidi S; Li S; Liu H; Bilal Hussain MA; Siddiqui S; Khan AP; Akhtar K; Siddiqui SA; Hasan SA; Hopper C; Bown SG; Liang R; Hasan T; Celli JP
    J Biomed Opt; 2023 Aug; 28(8):082809. PubMed ID: 37483565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of a low-cost, portable, LED-based device for PDT treatment of early-stage oral cancer in resource-limited settings.
    Liu H; Daly L; Rudd G; Khan AP; Mallidi S; Liu Y; Cuckov F; Hasan T; Celli JP
    Lasers Surg Med; 2019 Apr; 51(4):345-351. PubMed ID: 30168618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smartphone fluorescence imager for quantitative dosimetry of protoporphyrin-IX-based photodynamic therapy in skin.
    Ruiz AJ; LaRochelle EPM; Gunn JR; Hull SM; Hasan T; Chapman MS; Pogue BW
    J Biomed Opt; 2019 Dec; 25(6):1-13. PubMed ID: 31820594
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical evaluation of a mobile, low-cost system for fluorescence guided photodynamic therapy of early oral cancer in India.
    Siddiqui SA; Siddiqui S; Hussain MAB; Khan S; Liu H; Akhtar K; Hasan SA; Ahmed I; Mallidi S; Khan AP; Cuckov F; Hopper C; Bown S; Celli JP; Hasan T
    Photodiagnosis Photodyn Ther; 2022 Jun; 38():102843. PubMed ID: 35367616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer.
    de Souza AL; Marra K; Gunn J; Samkoe KS; Kanick SC; Davis SC; Chapman MS; Maytin EV; Hasan T; Pogue BW
    Br J Cancer; 2016 Sep; 115(7):805-13. PubMed ID: 27575852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule kinase inhibitors enhance aminolevulinic acid-mediated protoporphyrin IX fluorescence and PDT response in triple negative breast cancer cell lines.
    Palasuberniam P; Kraus D; Mansi M; Howley R; Braun A; Myers K; Chen B
    J Biomed Opt; 2021 Sep; 26(9):. PubMed ID: 34545713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multispectral autofluorescence imaging for detection of cervical lesions: A preclinical study.
    Bae SJ; Lee DS; Berezin V; Kang U; Lee KH
    J Obstet Gynaecol Res; 2016 Dec; 42(12):1846-1853. PubMed ID: 27748558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization and therapeutic effects of PDT mediated by ALA and MAL in the treatment of cutaneous malignant lesions: A comparative study.
    Lima CA; Goulart VP; Bechara EJ; Correa L; Zezell DM
    J Biophotonics; 2016 Dec; 9(11-12):1355-1361. PubMed ID: 27653310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron chelation promotes 5-aminolaevulinic acid-based photodynamic therapy against oral tongue squamous cell carcinoma.
    Qin J; Zhou C; Zhu M; Shi S; Zhang L; Zhao Y; Li C; Wang Y; Wang Y
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101907. PubMed ID: 32619712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
    Tyrrell JS; Campbell SM; Curnow A
    Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of hypoxia, oxygen consumption and recovery in vivo during ALA-photodynamic therapy using delayed fluorescence of Protoporphyrin IX.
    Scholz M; Petusseau AF; Gunn JR; Shane Chapman M; Pogue BW
    Photodiagnosis Photodyn Ther; 2020 Jun; 30():101790. PubMed ID: 32344195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light Fractionation Significantly Increases the Efficacy of Photodynamic Therapy Using BF-200 ALA in Normal Mouse Skin.
    de Bruijn HS; Brooks S; van der Ploeg-van den Heuvel A; Ten Hagen TL; de Haas ER; Robinson DJ
    PLoS One; 2016; 11(2):e0148850. PubMed ID: 26872051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
    Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H
    Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines.
    Ji Z; Yang G; Vasovic V; Cunderlikova B; Suo Z; Nesland JM; Peng Q
    J Photochem Photobiol B; 2006 Sep; 84(3):213-20. PubMed ID: 16709459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence staining of oral cancer using a topical application of 5-aminolevulinic acid: fluorescence microscopic studies.
    Leunig A; Mehlmann M; Betz C; Stepp H; Arbogast S; Grevers G; Baumgartner R
    J Photochem Photobiol B; 2001 Apr; 60(1):44-9. PubMed ID: 11386680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
    Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration.
    Chang SC; Buonaccorsi G; MacRobert AJ; Bown SG
    Lasers Surg Med; 1997; 20(3):254-64. PubMed ID: 9138254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment.
    Stepp H; Beck T; Pongratz T; Meinel T; Kreth FW; Tonn JCh; Stummer W
    J Environ Pathol Toxicol Oncol; 2007; 26(2):157-64. PubMed ID: 17725542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of perianal Paget's disease using photodynamic therapy with assistance of fluorescence examination: case report.
    Li L; Deng Y; Zhang L; Liao W; Luo R; Huang Z
    Lasers Med Sci; 2009 Nov; 24(6):981-4. PubMed ID: 19242772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.